Scorpion Therapeutics Email Formats

Biotechnology Research • United States • 21-50 Employees

Scorpion Therapeutics Email Formats

Scorpion Therapeutics uses 3 email formats. The most common is {first name}{last name} (e.g., johndoe@scorpiontx.com), used 76.9% of the time.

Format	Example	Percentage
{first name}{last name}	johndoe@scorpiontx.com	76.9%
{first initial}	j@scorpiontx.com	15.4%
{2char}	{2char}@scorpiontx.com	7.7%

Key Contacts at Scorpion Therapeutics

David Aizenman

Senior Director Outsourcing & Vendor Management

Aaron Boudreau

Senior Director, Target Biology

Patrick Visperas

Director Of Biochemical And Cellular Pharmacology

Ryan Chappell

Director, Laboratory Operations

Jacqueline Herlihy

Director, Quality Systems & Documentation

Jenny Yuan

Sr. Director, Head Of Statistical Programming

Felix Agbo

Sr. Director Clinical Pharmacology/Pharmacometrics

Company overview

Headquarters	United States
Phone number	+17812885760
Website	scorpiontx.com
NAICS	541714
Founded	2020
Employees	21-50
Socials

About Scorpion Therapeutics

Scorpion is a clinical-stage, precision oncology company developing transformational targeted therapies for patients with cancer. We have built proprietary and fully-integrated discovery capabilities leveraging the most advanced technologies across cancer biology, medicinal chemistry and data sciences. Our current pipeline, led by our mutant-selective PI3Ka program STX-478, consists of three internally discovered clinical product candidates in addition to multiple discovery-stage programs. Our focus is on solving current gaps in therapeutic options for patients with cancer by discovering and developing exquisitely-selective product candidates against well-validated, previously undruggable targets to improve patient outcomes.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Director

Entry

Senior

Employees by Department

Scorpion Therapeutics has 10 employees across 6 departments.

Departments

Number of employees

Funding Data

Explore Scorpion Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2021-02-07	5	$162,000,000
2024-08-16	6	$150,000,000

Funding Insights

$312,000,000

Total funding amount

$150,000,000

Most recent funding amount

Number of funding rounds

Scorpion Therapeutics Tech Stack

Discover the technologies and tools that power Scorpion Therapeutics's digital infrastructure, from frameworks to analytics platforms.

reCAPTCHA

Security

Cloudflare Bot Management

Security

WP Rocket

Caching

lit-element

JavaScript libraries

Google Maps

Maps

lit-html

JavaScript libraries

Cloudflare

CDN

Apple iCloud Mail

Webmail

HTTP/3

Miscellaneous

HSTS

Security

PHP

Programming languages

WordPress

Blogs

Frequently asked questions

Scorpion Therapeutics is located in US.

You can reach Scorpion Therapeutics at +17812885760.

Scorpion Therapeutics was founded in 2020, making it 6 years old. The company has established itself as a significant player in its industry over this time.

Scorpion Therapeutics has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

Scorpion Therapeutics has raised a total of $312,000,000 across 2 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at Scorpion Therapeutics

David Aizenman

Senior Director Outsourcing & Vendor Management

Aaron Boudreau

Senior Director, Target Biology

Patrick Visperas

Director Of Biochemical And Cellular Pharmacology

Ryan Chappell

Director, Laboratory Operations

Jacqueline Herlihy

Director, Quality Systems & Documentation

Jenny Yuan